Business Context and Reporting Period
This Form 6-K filing by Immatics N.V. is dated October 27, 2025. The report discloses a corporate governance update regarding the appointment of Amie Krause as the Company's Chief People Officer, effective October 27, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The primary material change disclosed is the addition of Amie Krause to the executive leadership team. Ms. Krause brings over 20 years of experience in human resources and organizational growth within the biopharmaceutical sector, with prior leadership roles at Dompe, Revance Therapeutics, Atara Biotherapeutics, and Amgen.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, operational outlook, risk factors, contingencies, or unusual items. The document serves solely to announce the executive appointment and incorporates the associated press release by reference.
Key Facts for Investor Verification
- Amie Krause has been appointed Chief People Officer effective October 27, 2025.
- Ms. Krause's background includes senior HR leadership at major biopharmaceutical companies including Amgen and Atara Biotherapeutics.
- This filing contains no financial data; investors should refer to the Company's most recent Form 20-F or quarterly reports for financial performance.